問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
National Taiwan University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2024-08-01 - 2031-12-31
Condition/Disease
Test Drug
Participate Sites1Sites
Recruiting1Sites
2019-04-01 - 2023-07-18
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Keytruda
Participate Sites5Sites
Recruiting5Sites
2022-07-01 - 2024-03-31
Participate Sites4Sites
Recruiting3Sites
Terminated1Sites
2025-05-06 - 2033-12-31
Participate Sites3Sites
2024-06-01 - 2027-12-31
Recruiting4Sites
2012-07-01 - 2015-07-31
Terminated4Sites
2009-09-25 - 2010-04-25
Terminated3Sites
2013-08-13 - 2018-01-15
Participate Sites2Sites
Terminated2Sites
2018-10-01 - 2024-08-31
2017-06-01 - 2026-12-31
Renal Cell Carcinoma Post Nephrectomy
Keytruda®
Terminated5Sites
全部
